Skip to main content
. Author manuscript; available in PMC: 2021 Sep 3.
Published in final edited form as: Mol Genet Metab. 2020 Sep 3;131(1-2):267–276. doi: 10.1016/j.ymgme.2020.08.006

Table 3.

Characteristics of liver disease in 73 ARPKD patients evaluated at the NIH Clinical Center.

Number (%)
Portal Hypertension 51 of 72* (71)
Males with portal hypertension 25 of 51
Females with portal hypertension 26 of 51
Esophagogastroduodenoscopy performed 45 of 72 (63)
Esophageal Varices 31 of 45 (69)
Variceal Banding 17 of 31 (55)
Variceal Bleeding 6 of 31 (19)
First visit Liver Echogenicity Normal/Mildly Increased 21 of 72 (29)
First Visit Liver Echogenicity Moderately/Severely Increased 51 of 72 (71)
Liver echogenicity progressed during the study 14 of 72 (19)
First visit Intrahepatic Cysts 29 of 72 (40)
First Visit Dilated Common Bile Duct 38 of 71 (54)
Biliary cystic disease progressed during the study 20 of 57 (35)
Cholangitis** 10 of 73 (14)

This table presents data on all patients evaluated under this study (13 with single and 60 with multiple visits).

*

One patient with hereditary spherocytosis was excluded.

**

Four out of 10 patients had recurrent cholangitis.